Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States.
Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States.
复制标题
DOI：
10.1080/21645515.2022.2148825
复制
发表时间：
2022-12-30
影响因子：
4.8
通讯作者：
中科院分区：
文献类型：
--
作者：
目前尚不清楚COVID-19大流行如何影响人乳头瘤病毒（HPV）疫苗的接种，以及哪些社会人口群体可能受到最大的影响。我们旨在评估美国大流行之前和期间HPV疫苗接种（开始和完成）的差异。我们使用2019年至2020年全国免疫调查-青少年（NIS-Teen）的数据进行了一项横断面研究，根据医疗保健提供者的确认报告，比较了2019年与2020年的疫苗启动和完成率。加权逻辑回归分析估计了青少年和父母特征的疫苗启动和完成的几率。2019年有18,788名青少年，2020年有20,162名。从2019年到2020年，HPV疫苗启动率增加了3.6%（71.5%对75.1%），完成率增加了4.4%（54.2%对58.6%）。在2020年，与非西班牙裔黑人青少年相比，非西班牙裔白色青少年启动（aOR = 0.62，95% CI：0.49，0.79）和完成（aOR = 0.71，95% CI：0.58，0.86）疫苗接种的可能性显著降低。此外，与生活在贫困线以下的青少年相比，生活在贫困线以上的青少年也不太可能开始HPV疫苗接种（aOR = 0.63，95% CI：0.49，0.80）或完成接种（aOR = 0.73，95% CI：0.60，0.90）。在2020年COVID-19大流行期间，一些历史上处于贫困线以上的社会经济群体接种HPV疫苗的可能性较低。大流行对HPV疫苗接种的影响可能超越传统的获得护理因素。
It is unclear how the COVID-19 pandemic impacted human papillomavirus (HPV) vaccine uptake and which sociodemographic groups may have been most impacted. We aimed to assess differences in HPV vaccine uptake (initiation and completion) before and during the pandemic in the United States. We conducted a cross-sectional study using data from the 2019 to 2020 National Immunization Surveys – Teen (NIS-Teen), comparing vaccine initiation and completion rates in 2019 vs. 2020, based on confirmed reports by a healthcare provider. Weighted logistic regression analysis estimated odds of vaccine initiation and completion for both adolescent and parental characteristics. There were 18,788 adolescents in 2019 and 20,162 in 2020. There was 3.6% increase in HPV vaccine initiation (71.5% vs. 75.1%) and a 4.4% in completion (54.2% vs. 58.6%) rates from 2019 to 2020. In 2020, Non-Hispanic White teens were significantly less likely to initiate (aOR = 0.62, 95% CI: 0.49, 0.79) and complete (aOR = 0.71, 95% CI: 0.58, 0.86) vaccine uptake compared with non-Hispanic Black teens. Additionally, teens who lived above the poverty line were also less likely to initiate HPV vaccination (aOR = 0.63, 95% CI: 0.49, 0.80) or complete them (aOR = 0.73, 95% CI: 0.60, 0.90), compared to those who lived below the poverty line. During the COVID-19 pandemic in 2020, some historically advantaged socioeconomic groups such as those living above the poverty line were less likely to receive HPV vaccine. The impact of the pandemic on HPV vaccine uptake may transcend traditional access to care factors.
登录
查看更多内容
影响因子：
13.8
作者：
Fischer SH;Ray KN;Mehrotra A;Bloom EL;Uscher-Pines L
通讯作者：
Uscher-Pines L
影响因子：
7.8
作者：
Darrat, Ilaaf;Tam, Samantha;Williams, Amy M.
通讯作者：
Williams, Amy M.
影响因子：
3.1
作者：
通讯作者：
--
过去如此现在：使用定性数据了解非裔美国成年人对 COVID-19 疫苗的犹豫。
影响因子：
3.9
作者：
Majee W;Anakwe A;Onyeaka K;Harvey IS
通讯作者：
Harvey IS
DOI：
10.1016/j.pvr.2016.02.001
发表时间：
2016-12
期刊：
Papillomavirus research (Amsterdam, Netherlands)
影响因子：
--
作者：
Choi Y;Eworuke E;Segal R
通讯作者：
Segal R